Broadcom named strategic vendor for Walmart virtualization solutions
Investing.com - Biocardia reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Biocardia announced earnings per share of $-0.170 on revenue of $212K. Analysts polled by Investing.com EPS of $-0.226 on revenue of $158.67K.
Biocardia 's are down 29.95% and is trading at $1.918 , still down 32.70% from its 52 week high of $2.85 set on Tuesday, April 12, 2022.
Biocardia follows other major Healthcare sector earnings this month
Biocardia's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar